Immunocore Holdings plc

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations ($55.3m) ($51.1m) ($35.5m) ($18.1m)
Profit or Loss ($103.9m) ($74.1m) ($131.5m) ($41.2m)
Other Adjustments To Reconcile Profit Loss ($2.9m) $165k $67k
Depreciation, Depletion and Amortization $6.4m $6.5m $6.4m $5.5m $6.1m $4.1m $4.2m $3.1m $3.6m
Depreciation $6.4m $6.5m $6.4m $5.5m $6.1m $4.1m $4.2m $3.3m $3.6m
Deferred Income Tax Expense (Benefit) ($3.5m) $5.8m ($3.8m) $14.8m $14.8m
Adjustments For Deferred Tax Of Prior Periods ($500k) ($379k) $18k ($150k)
Deferred Tax ($3.5m) ($3.8m) $14.8m $14.8m
Share-based Payment Arrangement, Noncash Expense $32.5m $34.2m $37.7m $33.9m
Adjustments For Share-Based Payments $3.1m $8.2m $35.9m $27.1m
Equity settled share-based payment expenses $666k $3.1m $8.2m $35.9m $27.1m
Other Nonoperating Income (Expense) ($897k) $14.2m $19.7m
Changes in operating assets and liabilities:
Change In Working Capital $49.0m ($9.3m) ($50.9m)
Increase (Decrease) in Accounts Receivable $17.9m $12.3m $7.3m ($26.5m)
Increase in receivables and other non-current assets ($1.5m) $1.8m ($532k) ($5.1m) ($32.1m)
Change In Receivables ($17.9m) ($12.3m) ($7.3m) ($26.5m)
Changes In Account Receivables ($26.3m) ($17.9m) ($12.3m) ($7.3m) ($26.5m)
Increase (Decrease) in Accounts Payable $2.6m $7.3m ($2.5m) $2.3m
Increase in trade and other payables $5.3m $9.9m ($3.8m) $9.5m $38.7m
Change In Payables And Accrued Expense $41.7m $78.8m $13.4m $2.3m
Decrease in deferred revenue ($24.5m) ($21.1m) ($20.1m)
Change In Accrued Expense $41.8m $39.1m $71.5m $15.9m $11.8m
Change In Other Current Assets ($4.7m) ($4.2m) ($6.2m) ($10.3m)
Change In Other Current Liabilities $356k ($3.6m) ($1.6m) ($2.1m) ($3.8m)
Net Cash Provided by (Used in) Operating Activities ($16.6m)
($101.4m) -509.74%
($60.6m) +40.25%
($96.1m) -58.67%
($25.9m) +73.06%
$2.9m +111.36%
$26.1m +786.43%
($10.7m) -141.10%
($35.0m) -226.34%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($3.5m) ($4.1m) ($3.1m) ($1.0m) ($1.8m) $5.4m $5.2m $4.3m ($6.2m)
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $0 $82k $675k $77k $5k
Marketable Securities, Unrealized Gain (Loss) $14.6m $19.7m
Other investing activities $3.2m $15k $2.4m
Net Other Investing Changes $20k $2.9m
Net cash flows from / (used in) investing activities $58.0m ($4.1m) $467k ($367k) $193k
Net Cash Provided by (Used in) Investing Activities ($5.4m) ($355.1m) ($16.3m) $7.8m
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt $0 ($3.9m) $0
Repayments Of Borrowings Classified As Financing Activities $43.5m
Issuance Of Debt $0 $402.5m $0 $0
Long Term Debt Issuance $0 $402.5m $0 $0
Net Issuance Payments Of Debt $0 $352.5m $0 ($50.0m)
Net Long Term Debt Issuance $0 $352.5m $0 ($50.0m)
Long Term Debt Payments $0 ($50.0m) $0 $0
Repayment Of Debt $0 ($50.0m) $0 $0
Issuance Of Capital Stock $0 $0 $0 $0
Common Stock Issuance $0 $0 $0 $0
Dividends Paid Ordinary Shares Per Share $0.01
Cash Dividends Paid $0 $0
Net Other Financing Charges ($21.0m) ($15.4m) ($15.4m)
Net cash flows from financing activities $101k
$55.1m +54481.19%
$115.9m +110.32%
$204.6m +76.50%
$114.5m -44.07%
Net Cash Provided by (Used in) Financing Activities $34.3m
$343.9m +901.23%
$12.4m -96.40%
$23.3m +88.27%
Beginning Cash Position $402.5m $442.6m $455.7m $487.9m
Cash and cash equivalents at beginning of the year $124.4m $74.0m $129.7m $237.9m $332.5m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.3m ($1.7m) $26.7m $849k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $442.6m $455.7m $467.7m $484.1m
Effect Of Exchange Rate Changes $8.3m ($1.7m) $26.7m $849k
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Income Tax Expense (Benefit) ($5.6m) ($1.9m) $16.4m
Interest Expense Nonoperating $18.8m $12.2m
Additional Financial Items
Proceeds from Stock Options Exercised $34.3m $6.8m $12.4m
Adjustments For Current Tax Of Prior Period $43k ($100k) $370k $20k
Adjustments For Decrease Increase In Trade Account Receivable $1.8m ($532k) ($5.1m) ($32.1m)
Adjustments For Increase Decrease In Trade Account Payable $9.9m ($3.8m) $9.5m $38.7m
Adjustments For Unrealised Foreign Exchange Losses Gains ($618k) ($787k) $586k ($6.0m)
Foreign Currency Transaction Gain (Loss), before Tax ($13.2m) ($3.4m) $2.2m
Foreign Currency Transaction Gain (Loss), Unrealized ($13.8m) ($599k) $6.4m
Interest Received Classified As Operating Activities $1.5m $676k
Investment Income, Interest $18.0m $25.6m $16.5m
Payments Of Lease Liabilities Classified As Financing Activities $4.0m $4.4m $3.2m $3.2m
Proceeds from Contributed Capital $0 $0 $0
Purchase Of Intangible Assets Classified As Investing Activities $198k $0 $0 $410k
Loss for the year ($71.6m) ($103.9m) ($74.1m) ($131.5m) ($41.2m)
Net finance costs ($298k) $7.9m $1.2m $5.8m $4.5m
Foreign exchange movements $1.2m ($618k) ($787k) $586k ($6.0m)
Income tax credit ($16.5m) ($22.3m) ($13.3m) ($9.4m) ($2.9m)
Other working capital movements ($41k) ($150k) $577k
Cash used in operations ($17.3m) ($116.4m) ($101.5m) ($108.5m) ($25.3m)
Purchase of intangible assets ($51k) ($198k) $0 $0 ($410k)
Proceeds from investment in sub-leases $0 $57k $378k $549k $0
Gross proceeds from issue of share capital $0 $59.9m $83.2m $226.5m $116.8m
Costs from issue of share capital $0 ($738k) ($176k) ($15.5m) ($388k)
Exercise of share options $101k $27k $73k $952k $8.1m
Non-current interest-bearing loan received $0 $0 $37.5m $0 $43.5m
Repayment of principal loan liability $0 $0 ($43.5m)
Early settlement and other loan fees $0 $0 ($3.3m)
Repayment of lease liabilities $0 ($4.0m) ($4.4m) ($3.2m) ($3.2m)
Net foreign exchange difference on cash held $13k ($33k) ($84k) $16k $5.9m
Leasehold incentives $34.1m $0 $2.5m $0
Cash Flow From Continuing Financing Activities $34.3m $343.9m $12.4m $23.3m
Cash Flow From Continuing Investing Activities ($5.4m) ($355.1m) ($16.3m) $7.8m
Change In Account Payable $4.9m $2.6m $7.3m ($2.5m) $2.3m
Change In Other Working Capital ($8.0m) ($1k) ($387k) ($582k)
Change In Payable $2.6m $7.3m ($2.5m) $2.3m
Change In Prepaid Assets ($14.7m) $8.5m ($11.6m) ($6.7m) ($23.8m)
Changes In Cash $31.9m $14.8m ($14.7m) ($3.9m)
End Cash Position $442.6m $455.7m $467.7m $484.1m
Financing Cash Flow $34.3m
$343.9m +901.23%
$12.4m -96.40%
$23.3m +88.27%
Free Cash Flow ($2.5m) $20.9m ($15.1m) ($41.2m)
Investing Cash Flow ($5.4m) ($355.1m) ($16.3m) $7.8m
Net Foreign Currency Exchange Gain Loss $13.8m $599k ($6.4m) ($8.5m)
Net Intangibles Purchase And Sale $0 ($496k) ($1.6m)
Net PPE Purchase And Sale ($5.4m) ($5.1m) ($4.3m) ($6.2m)
Operating Gains Losses $13.8m $4.5m ($6.4m) ($8.5m)
Other Non Cash Items $2.1m $3.8m $4.5m
Proceeds From Stock Option Exercised $34.3m $6.8m $12.4m $23.3m
Purchase Of Intangibles $0 ($496k) ($1.6m)
Purchase Of PPE ($5.4m) ($5.2m) ($4.3m) ($6.2m)
Sale Of PPE $0 $44k $0 $0
Stock Based Compensation $32.5m $34.2m $37.7m $33.9m
Unrealized Gain Loss On Investment Securities ($14.6m) ($19.7m) ($14.4m)
Net Investment Purchase And Sale ($350.0m) ($12.0m) $14.0m
Purchase Of Investment ($350.0m) ($30.0m) $0
Sale Of Investment $0 $18.0m $14.0m
Increase in net cash and cash equivalents $41.5m ($50.4m) $55.8m $108.2m $88.8m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $14.8m ($14.7m)
Interest paid on non-current interest-bearing loans $0 $0 ($291k) ($4.1m) ($3.6m)
Income Taxes Paid, Net ($66k) $13.5m $40.3m $12.4m ($618k) ($977k) $510k $4.6m